ClinPharm Consulting Expanding to Accommodate Increased Demand for Pharmacokinetic Services

Online, February 17, 2011 (Newswire.com) - ClinPharm Consulting, a specialized consulting firm offering a unique paradigm for empowering drug development pipelines, has moved into new offices in RTP and is hiring more employees to accommodate an expanding portfolio of clients and projects.

"We are experiencing high demand for our expertise in pharmacokinetics and overall clinical pharmacology drug development services," said Chief Scientific Officer M. Alexander Shaw, Ph.D., adding, "Our complete knowledge of clinical pharmacology and high-quality scientific writing is paying dividends for our clients and their drug pipelines."

According to Dr. Shaw, small biopharmaceutical companies with minimal R&D infrastructure as well as mid-sized and large pharmaceutical companies are seeking access to the firm's specialized expertise with both traditional and population PK capabilities at an affordable cost.

In response to its increase in clientele, ClinPharm Consulting has secured a larger office space that will allow for further expansion and additional staff. The company is actively refining its internal processes and structure to accommodate new employees, while ensuring continued focus on quality, customer service, and value that has come to symbolize its reputation in the industry.

"We are becoming a clearinghouse for clinical pharmacology drug development knowledge and one of the leading consulting firms offering clinical pharmacokinetic services," Geoffrey Banks, Ph.D., ClinPharm Consulting President & CEO said.

"Our goal is to be the preeminent consulting firm in clinical pharmacology and we are taking the right steps in that direction," he added.

ClinPharm Consulting has been steadily growing its client portfolio of companies seeking assistance from the firm's team of credentialed industry veterans boasting experience from scientific and strategic planning to operational implementation of drug development programs dealing with both small molecules and biologics.

For more information on ClinPharm Consulting services, email [email protected] or visit www.clinpharmconsulting.com.

ABOUT CLINPHARM CONSULTING
ClinPharm Consulting is a specialized consulting firm offering a unique paradigm for empowering drug development pipelines. Our business model focuses on matching scientific and pharmacokinetic/pharmacodynamic expertise with superior writing capabilities to maximize the impact of individual studies on an overall clinical pharmacology program. We specialize in helping small biopharmaceutical companies with minimal R&D infrastructure find scalable solutions for emerging early phase drug development challenges, providing an unmatched combination of technical expertise and robust understanding of clinical pharmacology from a scientific, regulatory and clinical conduct perspective.

The breadth of our experience allows ClinPharm Consulting to be a complete resource for clients to set up their drug development programs for success. ClinPharm Consulting typically engages clients as early as the IND planning stage to develop robust clinical pharmacology strategies and then works as a horizontally integrated, in-house resource to assist with the execution and analysis of those strategies. Our efforts not only include the design, conduct, and analysis of clinical pharmacology studies but also helping clients transition from nonclinical research into early phase clinical trials as well as transitioning from healthy volunteers into patients with the target disease. For more information, visit www.clinpharmconsulting.com.